Novel SOD1 mutation p.V31A identified with a slowly progressive form of amyotrophic lateral sclerosis.

Autor: Dangoumau A; UMR INSERM U930, Université François-Rabelais, Tours, PRES Centre - Val de Loire Université, France., Verschueren A, Hammouche E, Papon MA, Blasco H, Cherpi-Antar C, Pouget J, Corcia P, Andres CR, Vourc'h P
Jazyk: angličtina
Zdroj: Neurobiology of aging [Neurobiol Aging] 2014 Jan; Vol. 35 (1), pp. 266.e1-4. Date of Electronic Publication: 2013 Aug 15.
DOI: 10.1016/j.neurobiolaging.2013.07.012
Abstrakt: The SOD1 gene encoding the superoxide dismutase 1 (SOD1) protein is mutated in approximately 15% of familial amyotrophic lateral sclerosis (ALS) and 3% of sporadic ALS. We identified a novel mutation in SOD1 in a man who presented at age 49 with lower limb stiffness, and at age 53, a spastic paraparesia with distal muscular atrophy in the lower limbs and fasciculations in the quadriceps. A diagnosis of ALS was established. Eleven years after disease onset his condition continues gradually and slowly to deteriorate. The heterozygous mutation observed in exon 2 resulted in a valine to alanine substitution at position 31 in the β-barrel domain of the SOD1 protein. Functional analysis in NSC34 cells showed that the overexpression of the mutant form of SOD1(V31A) induced aggregates and decreased cell viability. This mutation is located outside of the regions carrying most of the ALS-related mutations (i.e., the catalytic center, the region of dimerization, and the loops between the β-strands of the β-barrel). In conclusion, we identified a novel SOD1 mutation in a patient with slow disease progression and supported the idea that different SOD1 mutations can lead to distinct ALS phenotypes.
(Copyright © 2013 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: